363 related articles for article (PubMed ID: 24092657)
1. Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making?
Woodford N; Wareham DW; Guerra B; Teale C
J Antimicrob Chemother; 2014 Feb; 69(2):287-91. PubMed ID: 24092657
[TBL] [Abstract][Full Text] [Related]
2. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Stock I
Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
[TBL] [Abstract][Full Text] [Related]
3. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman.
Dortet L; Poirel L; Al Yaqoubi F; Nordmann P
Clin Microbiol Infect; 2012 May; 18(5):E144-8. PubMed ID: 22404169
[TBL] [Abstract][Full Text] [Related]
4. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.
Nordmann P
Med Mal Infect; 2014 Feb; 44(2):51-6. PubMed ID: 24360201
[TBL] [Abstract][Full Text] [Related]
5. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
Oteo J; Miró E; Pérez-Vázquez M; Navarro F
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
[TBL] [Abstract][Full Text] [Related]
6. Investigation of VIM, IMP, NDM-1, KPC AND OXA-48 enzymes in Enterobacteriaceae strains.
Demir Y; Zer Y; Karaoglan I
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1127-33. PubMed ID: 26051720
[TBL] [Abstract][Full Text] [Related]
7. New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
Deshpande P; Rodrigues C; Shetty A; Kapadia F; Hedge A; Soman R
J Assoc Physicians India; 2010 Mar; 58():147-9. PubMed ID: 20848811
[TBL] [Abstract][Full Text] [Related]
8. Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases--United States, 2010-2015.
Lyman M; Walters M; Lonsway D; Rasheed K; Limbago B; Kallen A
MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(47):1315-6. PubMed ID: 26633574
[TBL] [Abstract][Full Text] [Related]
9. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
Tängdén T; Giske CG
J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628
[TBL] [Abstract][Full Text] [Related]
10. The carbapenemase threat in the animal world: the wrong culprit.
Poirel L; Stephan R; Perreten V; Nordmann P
J Antimicrob Chemother; 2014 Jul; 69(7):2007-8. PubMed ID: 24576948
[No Abstract] [Full Text] [Related]
11. Evaluation of two new commercial immunochromatographic assays for the rapid detection of OXA-48 and KPC carbapenemases from cultured bacteria.
Glupczynski Y; Evrard S; Ote I; Mertens P; Huang TD; Leclipteux T; Bogaerts P
J Antimicrob Chemother; 2016 May; 71(5):1217-22. PubMed ID: 26825120
[TBL] [Abstract][Full Text] [Related]
12. Identification and screening of carbapenemase-producing Enterobacteriaceae.
Nordmann P; Gniadkowski M; Giske CG; Poirel L; Woodford N; Miriagou V;
Clin Microbiol Infect; 2012 May; 18(5):432-8. PubMed ID: 22507110
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the in-house made Carba-NP and Blue-Carba tests: Considerations for better detection of carbapenemase-producing Enterobacteriaceae.
Pires J; Tinguely R; Thomas B; Luzzaro F; Endimiani A
J Microbiol Methods; 2016 Mar; 122():33-7. PubMed ID: 26773493
[TBL] [Abstract][Full Text] [Related]
14. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe.
Cantón R; Akóva M; Carmeli Y; Giske CG; Glupczynski Y; Gniadkowski M; Livermore DM; Miriagou V; Naas T; Rossolini GM; Samuelsen Ø; Seifert H; Woodford N; Nordmann P;
Clin Microbiol Infect; 2012 May; 18(5):413-31. PubMed ID: 22507109
[TBL] [Abstract][Full Text] [Related]
15. [KPC carbapenemases: what is at stake in clinical microbiology?].
Cuzon G; Naas T; Nordmann P
Pathol Biol (Paris); 2010 Feb; 58(1):39-45. PubMed ID: 19854586
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
Logan LK
Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
[TBL] [Abstract][Full Text] [Related]
17. An emerging public health problem: acquired carbapenemase-producing microorganisms are present in food-producing animals, their environment, companion animals and wild birds.
Guerra B; Fischer J; Helmuth R
Vet Microbiol; 2014 Jul; 171(3-4):290-7. PubMed ID: 24629777
[TBL] [Abstract][Full Text] [Related]
18. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers.
Huang TD; Poirel L; Bogaerts P; Berhin C; Nordmann P; Glupczynski Y
J Antimicrob Chemother; 2014 Feb; 69(2):445-50. PubMed ID: 24055766
[TBL] [Abstract][Full Text] [Related]
19. Current status of carbapenemases in Latin America.
Maya JJ; Ruiz SJ; Blanco VM; Gotuzzo E; Guzman-Blanco M; Labarca J; Salles M; Quinn JP; Villegas MV
Expert Rev Anti Infect Ther; 2013 Jul; 11(7):657-67. PubMed ID: 23879607
[TBL] [Abstract][Full Text] [Related]
20. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
